The failing health care system for adult patients with cystic fibrosis S P Conway, D E Stableforth, A K Webb Excellent paediatric care has ensured that most children important group and exposing our patients to the vagaries of local initiatives and gross inequality of service between with cystic fibrosis survive into adulthood.
1 2 Centre based care from a multidisciplinary cystic fibrosis team has been regions. The current guidelines from the Royal College of Physshown to deliver a better prognosis 3 and continuing optimal supervision delivered from multidisciplinary adult cystic icians recommend 3-4 consultant sessions and 2-3 sessions from another senior doctor per week per 50 patients. 7 In fibrosis centres has seen patient survival reach beyond the fourth decade of life. Antenatal screening, selective or the adult cystic fibrosis units at Birmingham, Leeds, and Manchester one consultant currently has overall reuniversal, will eventually reduce the proportion of paediatric patients further. 4 Cystic fibrosis is becoming presponsibility for over 200 patients. Historically the care for adult patients with cystic fibrosis has been assumed largely dominantly an adult disease. The adult cystic fibrosis clinics in Birmingham, Leeds, and Manchester currently look by interested physicians in addition to their existing clinical workload, and some continue busy respiratory and general after over 600 patients whereas five years ago this combined figure was approximately 400. Each of the three clinics has medical practices. As total patient numbers have increased, individuals inevitably receive less personal attention, dean average annual net increase of 20 patients.
Medical management has increased survival, not only spite the need for constant input from consultants and other experienced senior doctors, thus undermining the because care delivered by cystic fibrosis centres has improved with experience but also because there are more confidence of patients in the quality of care delivered. The accepted level of junior doctor support for every 50 treatment options to maintain patients in a good and stable clinical state. These include intensive use of oral and patients is five sessions of one registrar grade with a special interest in cystic fibrosis, in addition to the usual junior intravenous antibiotics, maximised nutrition with nasogastric or gastrostomy feeding, and the prescription of staffing of a medical team. The recommended professional support is: one clinical nurse specialist, two physionovel drugs such as DNase which can potentially increase survival further. Consequently many people with cystic therapists, one secretary, one part-time dietitian, and one part-time social worker. Based on these criteria, the levels fibrosis have a better quality of life, often with jobs, families, and concrete hopes for the future. Much can be done for of junior doctor and paramedical support in some of the larger regional adult cystic fibrosis units are sufficient for sicker patients too, helping them towards transplantation by attention to every detail of care, nasal intermittent 100 patients, approximately half the numbers actually attending. positive pressure ventilation, and continuous intravenous antibiotics. Cystic fibrosis has become very much the Many cystic fibrosis units are currently primed with monies from the UK Cystic Fibrosis Trust which enables province of the adult respiratory physician, and as it becomes increasingly complex so it becomes increasingly the appointment of research fellows, cystic fibrosis clinical nurse specialists, and other necessary staff. Only some of expensive to resource.
As paediatricians have transferred more and healthier these positions have been financed by hospital trusts. Even the inadequate infrastructure of the existing care system patients, the adult physician has had the privilege of caring for a growing number of knowledgeable, organised, and for adult patients with cystic fibrosis remains dependent on the continuing generosity of the Cystic Fibrosis Trust's articulate adults. However, as a consequence of this steady growth and the high expectations of patients and their clinical support and improvement grants, a maximum of £25 000 per annum and given according to the clinic's relatives, the demands on some centres will outstrip their ability to continue to provide a first class service. This will patient numbers. These grants are often "topped" up by the cystic fibrosis unit from other charity sources and show as reduced consultant input per patient, overcrowded clinics, no comprehensive annual review, reduced ward "slush funds" in order to fund full-time junior doctors. Cystic Fibrosis Trust support remains a "sine qua non" in supervision, a lack of the clinical research necessary to maintain centre credibility, and poor morale amongst overmost units and if it were withdrawn some would simply not be able to deliver effective health care. worked staff. These consequences are inevitable unless the hospital trusts recognise that resources flowing to the major The lack of proper support for cystic fibrosis care typifies the short sightedness of present funding levels. Medication cystic fibrosis centres must reflect patient needs.
For some years there has been awareness of the potential accounts for over 60% of the total cost of cystic fibrosis care. Suboptimal care results in sicker patients who inmedical and financial problems posed by the rapid increase in the adult cystic fibrosis population. Efforts have been evitably cost more. It is not inevitable, however, that older patients need vastly more expensive treatments as, with made to define, recommend, and answer these needs. In 1990 the Department of Health commissioned a Clinical optimal care, the annual decline in pulmonary function can be marginal, complications can be dealt with promptly, Standards Advisory Group 5 to evaluate the access and availability of specialist cystic fibrosis services in the UK.
and their deleterious effects minimised. Overall costs for adults could be significantly reduced if staffing levels were Clinical guidelines and standards of care for adult cystic fibrosis patients have been published by the Royal College sufficient to allow more frequent review of patients by senior doctors and paramedical staff with special expertise of Physicians.
6 7 The cost of resourcing cystic fibrosis care has been carefully evaluated on several occasions.
8-10 These in cystic fibrosis. Adult cystic fibrosis units struggle with inadequate bed recommendations are not being met, laying bare a lack of advance planning or central strategy development for this bases. Despite the enthusiastic uptake of home intravenous group.bmj.com on April 19, 2017 -Published by http://thorax.bmj.com/ Downloaded from antibiotic treatment which now accounts for over half of individual patient accurately and not based on an "average patient" as disease severity and the intensity of treatment all "iv days" in some centres, there is daily pressure on a can vary widely. Costs must be accurately assessed or limited number of hospital beds. There has been no ad-"banded" for each patient annually for the coming financial vance planning for the predicted increase in adult patient year and the purchasers appropriately charged. Accurate numbers. The published guidelines on bed numbers, based billing is an essential prerequisite to proper funding for a on paediatric cystic fibrosis care, recommend six per 50 cystic fibrosis unit. patients, but are not being met and are inadequate for an The care system for adult patients is already in crisis in adult population with more advanced disease. Birmingham some parts of the UK. More recently established units will has no dedicated adult cystic fibrosis beds. For patients almost certainly encounter the above problems as their with Pseudomonas aeruginosa infection Leeds has eight beds patient numbers increase. Life expectancy for adult patients and Manchester 10. Patients chronically infected with will continue to rise. Those in receipt of a lung transplant Burkholderia cepacia have to compete for beds with nonstill need continuing care in the cystic fibrosis centres for cystic fibrosis patients on other acute wards.
this multi-system disease. Severely ill patients with FEV 1 Adult beds are increasingly blocked by severely ill values below 20% predicted can be kept alive for long patients without the domestic support to leave hospital, periods with intensive treatments. The likely outcome of often for months. Emergency admissions are to wards ill failure to increase resources is "gridlock" with existing equipped for the special needs of sick young adults. Acute units being incapable of accepting new referrals. Unless admissions are usually accommodated within 2-3 days in adequate funding is directed to adult cystic fibrosis care Manchester, but may wait for up to two weeks in Birand further consultants appointed, patients are likely to mingham and Leeds. Early intervention in acute respiratory drift to non-specialist adult respiratory units which are ill exacerbations is crucial to minimise permanent lung damequipped for their special needs. Their alternative will be age.
11 Patients who are failing to improve on home intrato remain with their paediatrician, usually an inadequate venous antibiotic treatment need admission, not merely option for adolescents with a chronic disease, and one that another week of home treatment in the hope that "things the paediatric services will not be able to support in the will get better". Transition from the paediatric to the adult long term. Adult patients with cystic fibrosis need powerful care system should be smooth and planned, but is not voices to argue their case. helped by having to mix with older adults in a general chest ward as in Birmingham.
12 None of these is achievable 
